IP Library Granted Patent US 12,139,479
Granted Patent B2
US 12,139,479 · App. 17/934,629 · Granted Nov 12, 2024

Heterocycle substituted pyridine derivative antifungal agents

Inventors: Michael Trzoss (San Diego, CA); Jonathan Covel (San Diego, CA); Karen Joy Shaw (Poway, CA); Peter Webb (San Diego, CA)
Assignee: Basilea Pharmaceutica International AG, Allschwil
C07D413/14A61P31/10C07D401/14C07D413/04C07D417/14C07D471/04C07F9/65583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,139,479
App. No.
17/934,629
Granted
Nov 12, 2024
Kind
B2
Abstract

Described herein are heterocycle substituted pyridine derivative antifungal agents and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of fungal diseases and infections.

Claims (17)

1. A compound

or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, stereoisomer, mixture of stereoisomers, or isotopic variant thereof.

2. A compound

3. A pharmaceutical composition, comprising:

the compound of claim 1 or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, stereoisomer, mixture of stereoisomers, or isotopic variant thereof; and

at least one pharmaceutically acceptable excipient.

4. A pharmaceutical composition, comprising:

the compound of claim 2 ; and

at least one pharmaceutically acceptable excipient.

5. A method of treating a fungal disease in a subject in need thereof, the method comprising:

administering to the subject a therapeutically effective amount of the compound of claim 1 or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, stereoisomer, mixture of stereoisomers, or isotopic variant thereof.

6. A method of treating a fungal disease in a subject in need thereof, the method comprising:

administering to the subject a therapeutically effective amount of the compound of claim 2 .

7. A method of treating a fungal disease in a subject in need thereof, the method comprising:

administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 3 .

8. A method of treating a fungal disease in a subject in need thereof, the method comprising:

administering to the subject a therapeutically effective amount of the pharmaceutical composition of claim 4 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2023
From: AMPLYX PHARMACEUTICALS, INC.
To: BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL
Reel/Frame 065843/0001 →
ASSIGNEE ADDRESS CORRECTION Recorded Mar 10, 2023
From: AMPLYX PHARMACEUTICALS, INC.
To: AMPLYX PHARMACEUTICALS, INC.
Reel/Frame 063025/0820 →
Continuity (4)
Continuation 16770476
Provisional Application 62649225 · Mar 28, 2018
Provisional Application 62595894 · Dec 7, 2017
Related Publication 20230065881A1 · Mar 2, 2023
Cited By (1)
US 12,521,406